New treatment for food allergies in kids moves closer to finish line ...Middle East

An existing asthma treatment shows promise for reducing food allergies in children and is one step closer to approval, which could come by the end of March.   Early data from a federally funded clinical trial showed children who received injections of the monoclonal antibody omalizumab could consume higher doses of peanut, egg, milk and cashew without allergic reactions compared with those who received a placebo.  Omalizumab, marketed as Xolair and developed by Genentech and Novartis, has been on the market since 2003 as a treatment for allergy-induced asthma, chronic hives and an inflammatory sinus disease called chronic rhinosinusitis with nasal polyps.  The companies last week

Hence then, the article about new treatment for food allergies in kids moves closer to finish line was published today ( Wednesday 27/12/2023 - 09:36 PM ) and is available on The Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( New treatment for food allergies in kids moves closer to finish line )

Also on site :

• My Big Family Once Formed the Backbone of My Life. Then, We Discovered My Sister’s Horrific Actions. Now Nothing Is the Same.
• ‘Fire Country’ Announces Major Change After Season 4 Cast Shake-Up
• Nearly 14,000 Pounds of Grilled Chicken Products Recalled for a Potentially Life-Threatening Reason—What to Know